All Stories

  1. Efficacy and Safety of Pitavastatin in Children and Adolescents at High Future Cardiovascular Risk

    Article • The Journal of Pediatrics, August 2015, Elsevier

    Dr Albert Wiegman

  2. Gonadal steroids, gonadotropins and DHEAS in young adults with familial hypercholesterolemia who had initiated statin therapy in childhood

    Article • Atherosclerosis, August 2015, Elsevier

    Dr Albert Wiegman

  3. Early initiation of statin treatment in children with familial hypercholesterolaemia

    Article • Current Opinion in Lipidology, June 2015, Wolters Kluwer Health

    Dr Albert Wiegman

  4. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment

    Article • European Heart Journal, May 2015, European Society of Cardiology

    Dr Albert Wiegman

  5. RETRACTED: Design of a Phase 3, Double-Blind, Randomized Trial of Lomitapide vs. Placebo in Pediatric Patients with Homozygous Familial Hypercholesterolemia

    Article • Journal of Clinical Lipidology, May 2015, Elsevier

    Dr Albert Wiegman

  6. Long-Term Statin Treatment in Children with Familial Hypercholesterolemia: More Insight into Tolerability and Adherence

    Article • Pediatric Drugs, February 2015, Springer Science + Business Media

    Dr Albert Wiegman

  7. Ten-Year Follow-up After Initiation of Statin Therapy in Children With Familial Hypercholesterolemia

    Article • JAMA, September 2014, American Medical Association (AMA)

    Dr Albert Wiegman

  8. Statins for children with familial hypercholesterolemia

    Article • July 2014, Wiley

    Dr Albert Wiegman

  9. EFFICACY AND SAFETY OF ROSUVASTATIN THERAPY FOR CHILDREN AND ADOLESCENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA: RESULTS FROM THE CHARON STUDY

    Article • Journal of the American College of Cardiology, April 2014, Elsevier

    Dr Albert Wiegman

  10. EFFECT OF ROSUVASTATIN THERAPY ON ARTERIAL WALL CHANGES IN CHILDREN AND ADOLESCENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA: RESULTS FROM THE CHARON STUDY

    Article • Journal of the American College of Cardiology, April 2014, Elsevier

    Dr Albert Wiegman

  11. HOMOZYGOUS AUTOSOMAL DOMINANT HYPERCHOLESTEROLEMIA IN THE NETHERLANDS: PREVALENCE, GENOTYPE-PHENOTYPE RELATIONSHIP AND CLINICAL OUTCOME

    Article • Journal of the American College of Cardiology, April 2014, Elsevier

    Dr Albert Wiegman

  12. Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation

    Article • Journal of Clinical Lipidology, March 2014, Elsevier

    Dr Albert Wiegman

  13. Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation

    Article • International Journal of Cardiology, February 2014, Elsevier

    Dr Albert Wiegman

  14. Management of Hypercholesterolemia in Children

    Article • Pediatric Drugs, January 2014, Springer Science + Business Media

    Dr Albert Wiegman

  15. Design and baseline data of a pediatric study with rosuvastatin in familial hypercholesterolemia

    Article • Journal of Clinical Lipidology, September 2013, Elsevier

    Dr Albert Wiegman

  16. Statin therapy and secretory phospholipase A2 in children with heterozygous familial hypercholesterolemia

    Article • Atherosclerosis, August 2013, Elsevier

    Dr Albert Wiegman

  17. Familial Hypercholesterolemia: Advances in Understanding the Early Natural History

    Article • Current Cardiovascular Risk Reports, September 2012, Springer Science + Business Media

    Dr Albert Wiegman

  18. Follow-Up of Children Diagnosed with Familial Hypercholesterolemia in a National Genetic Screening Program

    Article • The Journal of Pediatrics, July 2012, Elsevier

    Dr Albert Wiegman

  19. Drug Therapy of Hypercholesterolaemia in Children and Adolescents

    Article • Drugs, April 2012, Springer Science + Business Media

    Dr Albert Wiegman, Albert Wiegman

  20. Statin use during pregnancy: a systematic review and meta-analysis

    Article • Expert Review of Cardiovascular Therapy, March 2012, Taylor & Francis

    Dr Albert Wiegman

  21. Lipoprotein-associated phospholipase A2 mass and activity in children with heterozygous familial hypercholesterolemia and unaffected siblings: Effect of pravastatin

    Article • Journal of Clinical Lipidology, January 2011, Elsevier

    Dr Albert Wiegman

  22. Treatment of dyslipidaemia in childhood

    Article • Expert Opinion on Pharmacotherapy, March 2010, Informa Healthcare

    Dr Albert Wiegman

  23. Efficacy and Safety of Rosuvastatin Therapy for Children With Familial Hypercholesterolemia

    Article • Journal of the American College of Cardiology, March 2010, Elsevier

    Dr Albert Wiegman

  24. Familial Dyslipidaemia in Children

    Article • January 2010, Karger Publishers

    Dr Albert Wiegman

  25. Predictive genetic testing for cardiovascular diseases: Impact on carrier children

    Article • American Journal of Medical Genetics Part A, December 2008, Wiley

    Dr Albert Wiegman, Professor Aad Tibben

  26. Atherogenic Lipoprotein Particle Size and Concentrations and the Effect of Pravastatin in Children with Familial Hypercholesterolemia

    Article • The Journal of Pediatrics, June 2008, Elsevier

    Dr Albert Wiegman

  27. Health-related quality of life of children with a positive carrier status for inherited cardiovascular diseases

    Article • American Journal of Medical Genetics Part A, January 2008, Wiley

    Dr Albert Wiegman, Professor Aad Tibben

  28. Effect of aging and obesity on the expression of dyslipidaemia in children from families with familial combined hyperlipidaemia

    Article • Clinical Science, January 2007, Portland Press Ltd.

    Dr Albert Wiegman

  29. Paraoxonase genotype and carotid intima???media thickness in children with familial hypercholesterolemia

    Article • European Journal of Cardiovascular Prevention & Rehabilitation, June 2006, Oxford University Press (OUP)

    Dr Mark Roest, Dr Albert Wiegman

  30. Oxidized Low-Density Lipoprotein in Children With Familial Hypercholesterolemia and Unaffected Siblings

    Article • Journal of the American College of Cardiology, May 2006, Elsevier

    Dr Albert Wiegman

  31. Plant stanols do not restore endothelial function in pre-pubertal children with familial hypercholesterolemia despite reduction of low-density lipoprotein cholesterol levels

    Article • The Journal of Pediatrics, April 2006, Elsevier

    Dr Albert Wiegman

  32. Effect of low-density lipoprotein receptor mutation on lipoproteins and cardiovascular disease risk: a parent–offspring study

    Article • Atherosclerosis, May 2005, Elsevier

    Dr Albert Wiegman

  33. HT03-IS-002 Familial hypercholesterolemia in children

    Article • Atherosclerosis Supplements, April 2005, Elsevier

    Dr Albert Wiegman

  34. Efficacy and Safety of Statin Therapy in Children With Familial Hypercholesterolemia

    Article • JAMA, July 2004, American Medical Association (AMA)

    Dr Albert Wiegman

  35. Steady-State Pharmacokinetics of Pravastatin in Children with Familial Hypercholesterolaemia

    Article • Clinical Drug Investigation, January 2004, Springer Science + Business Media

    Dr Albert Wiegman

  36. Arterial intima-media thickness in children heterozygous for familial hypercholesterolaemia

    Article • The Lancet, January 2004, Elsevier

    Dr Albert Wiegman

  37. The Apolipoprotein ε4 Allele Confers Additional Risk in Children with Familial Hypercholesterolemia

    Article • Pediatric Research, June 2003, Springer Science + Business Media

    Dr Albert Wiegman

  38. Family History and Cardiovascular Risk in Familial Hypercholesterolemia: Data in More Than 1000 Children

    Article • Circulation, March 2003, Wolters Kluwer Health

    Dr Albert Wiegman

  39. Surrogate markers of atherosclerosis: impact of statins

    Article • Atherosclerosis Supplements, March 2003, Elsevier

    Dr Albert Wiegman

  40. Vetstofwisselingsafwijkingen bij kinderenfamiliaire hypercholesterolemie cholesterol

    Article • Bijblijven, February 2003, Springer Science + Business Media

    Dr Albert Wiegman